GlaxoSmithKline Consumer Healthcare records 7.5 % growth for Q1 FY 2016

 

Net sales at Rs 990 crores recorded a growth of 7.5% over 2014 with PAT at Rs. 155 crores growing by 19.1% for the same period and PBT at Rs 238 crores growing by 20.1%.

Commenting on the results,  Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “The first quarter has begun on a positive note – Horlicks and Boost are among the top three HFD in the country. We continue to stay ahead of the category, increasing our market share and volumes. Our growth is a reflection of distribution expansion, enhanced marketing campaigns as we continue to bring nutrition to suit each lifestyle and support all lifecycle.”

"Our efforts for the future will be to continue to service the unmet needs of the consumers through health enhancing products backed by high science. We will continue to focus on our distribution process so that our products reach more people at price points that are competitive and thereby bringing health to everyone,” Kumar said.